Sort
78,016 grants matching “breast cancer”
Genetic Modifiers of Initiation and Progression of Mammary Cancer
$2,603,989Kent W Hunter · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Alliance for Clinical Trials in Oncology Operations Center
$2,603,385Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2020 · CA
The Center for Tumor-Immune Systems Biology at MSKCC
$2,601,900Christina S Leslie · Sloan-Kettering Inst Can Research · U54 · FY2023 · CA
Cancer Center Renovation Grant
$2,600,000University Of Maryland Baltimore · C06 · FY2004 · RR
Studies of Occupational Cancer
$2,599,567Qing Lan · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Eukaryotic Transcriptional Regulation
$2,594,312Paul A Wade · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Depleting S1P to reverse immune exclusion for effective cancer immunotherapy
$2,592,085Everett Stone · University Of Texas At Austin · R01 · FY2025 · CA
Molecular Pathogenesis of Breast Cancer
$2,592,021Columbia University Health Sciences · P01 · FY2005 · CA
Carolina Center of Cancer Nanotechnology Excellence
$2,590,876Joseph M Desimone · Univ Of North Carolina Chapel Hill · U54 · FY2010 · CA
Molecular Pathogenesis of Breast Cancer
$2,590,529Riccardo Dalla-Favera · Columbia University Health Sciences · P01 · FY2006 · CA
Quantitative Systems Biology
$2,589,986John D. Aitchison · Institute For Systems Biology · P50 · FY2016 · GM
CANCER EPIDEMIOLOGY IN ADVENTISTS--A LOW RISK GROUP
$2,589,615Loma Linda University · R01 · FY2001 · CA
A novel glycan-based selectin and complement inhibitor for at-home disease-modifying rescue of pain crisis in sickle cell disease
$2,589,070John Paderi John Paderi John Paderi · Ihp Therapeutics, Inc. · UG3 · FY2023 · NS
Genetic Modifiers of Initiation and Progression of Mammary Cancer
$2,588,783Kent W Hunter · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
DNA Sequencing and FACS Core Facilities
$2,587,962Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Plasma iNOS IVD Prognosticates Sepsis Prior to Organ Damage and Dysfunction
$2,585,963Robert J Webber · Research And Diagnostic Antibodies · RC3 · FY2010 · GM
DANA-FARBER/HARVARD SPORE IN BREAST CANCER
$2,584,815Dana-Farber Cancer Institute · P50 · FY2000 · CA
Epidemiology and Natural History of Cancer-Associated Viruses
$2,581,642Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
$2,580,000Daniel M Anderson · Healthpartners Institute · UG1 · FY2016 · CA
NAT'L COMPREHENSIVE CANCER CONTROL PROG: NAT'L BREAST & CERVICAL CANCER EARLY DET
$2,579,821Vivien W Chen · Lsu Health Sciences Center · U58 · FY2009 · DP
SPORE IN BREAST CANCER
$2,579,279Northwestern University · P50 · FY2000 · CA
Studies of Occupational Cancer (Pesticides)
$2,576,886Michael Alavanja · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
PHASE 1B CLINICAL TRIAL OF A CANDIDATE BREAST CANCER PREVENTION VACCINE
$2,575,108Washington University, The · · FY2015 · Department of the Army
Cancer Center Support Grant
$2,574,969New York University School Of Medicine · P30 · FY2005 · CA
Cancer Center Support Grant
$2,574,958New York University School Of Medicine · P30 · FY2004 · CA